Business
Pulmatrix Announces Publication Demonstrating Reduction of Bioaerosols with FEND, an OTC Nasal Hygiene Product Designed to Cleanse Airways of Airborne Particles
FEND Administration Lowered Exhaled Particles in Subjects Including Healthy Subjects and a COVID-19 Patient Partner Sensory Cloud to Distribute FEND
About this update from Pulmatrix, Inc.
[{"type":"text","content":"FEND Administration Lowered Exhaled Particles in Subjects Including Healthy Subjects and a COVID-19 Patient\n Partner Sensory Cloud to Distribute FEND Worldwide, with Pulmatrix Receiving Escalating Royalties upon Commencement of Sales\n\n\nLEXINGTON, Mass., Sept. 30, 2020 /PRNewswire/ – Pulmatrix, Inc. (NASDAQ: PULM), a clinical stage biopharmaceutical company developing innovative inhaled therapies for serious pulmonary and non-pulmonary disease using its patented iSPERSE™ technology, today announced the publication of data from partner Sensory Cloud detailing the utility of FEND, a hypertonic calcium chloride salt solution with nasal mister, in the reduction of bioaerosol generation in the airways. Pulmatrix licensed the rights to the Company's NasoCalm proprietary formulations (PUR003 and PUR006) to Sensory Cloud, now integral to the product FEND, with Sensory Cloud to market and distribute FEND, and Pulmatrix to receive escalating royalties, upon commencement of sales. \n\n \n \n \n \n \n \n\n \nThe publication, titled \"Nasal Calcium-Rich Salts for Cleaning Airborne Particles from the Airways of Essential Workers, Students and a Family in Quarantine\" and published in the journal Molecular Frontiers, was co-authored by Dr. David Edwards of Harvard (founder of Sensory Cloud), Dr. Robert Langer of MIT, and colleagues. Key findings of the study include:\nIn studies across adults and children, FEND nasal salt aerosols lowered exhaled particles by approximately 75% and outperformed surgical masks in the clearing of sub-micron particles The majority of particles exhaled during natural breathing are smaller in size than current hygiene practices, including face masks and social distancing, are designed to block Consistent with classical \"super spreading\" distributions, approximately 20% of subjects identified as Super Spreaders (of airborne particles), account for 80% of the overall exhaled aerosols FEND delivery suppressed exhaled aerosols 30 minutes post treatment by 78% overall for all (non-Covid-19) Super Spreaders FEND administration led to a similar reduction in bioaerosol production in a COVID-19 patient who appeared to develop with her infection an acute increase in bioaerosol production consistent with Super Spreader status\"We are pleased to announce the publication of data from our partners at Sensory Cloud which demo...